Cue Biopharma files Form 3 for Chief Medical Officer, Head of R&D Dominique Borie

Cue Biopharma filed a Form 3 for Dominique Christian Borie, naming him chief medical officer, head of research and development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002008790-26-000004), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Cue Biopharma Inc. filed a Form 3 with the SEC for Dominique Christian Borie, appointing him as Chief Medical Officer and Head of Research and Development. The filing was published via EDGAR on July 15, 2026.

Cue Biopharma filed a Form 3 for Dominique Christian Borie, naming him chief medical officer, head of research and development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002008790-26-000004), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here